中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
Ervamycine; 11-甲氧基水甘草碱 |
11-methoxytabersonine |
27773-39-3 |
C22H26N2O3 |
|
Emixustat盐酸盐 |
emixustat hydrochloride |
1141934-97-5 |
C16H25NO2*ClH |
|
Elacestrant 二盐酸盐 |
Elacestrant hydrochloride |
1349723-93-8 |
C30H40Cl2N2O2 |
|
Egenine; (6R,8S)-6,8-二氢-6-[(5S)-5,6,7,8-四氢-6-甲基-1,3-二氧杂环戊并[4,5-g]异喹啉-5-基]呋喃并[3,4-e]-1,3-苯并二氧杂环戊烯-8-醇 |
(+)-egenine |
6883-44-9 |
C20H19NO6 |
|
Eg5抑制剂VII |
6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-quinolin-2-one |
912953-25-4 |
C16H12F3NO |
|
Eg5抑制剂IV,VS-83 |
Eg5 Inhibitor IV, VS-83 |
909250-29-9 |
C14H11FN2OS |
|
EZH2甲基转移酶抑制剂(GSK126) |
GSK-126 |
1346574-57-9 |
C31H38N6O2 |
|
EZATIOSTAT游离的 |
γ-glutamyl-S-(benzyl)cysteinyl-(R)-(-)-phenylglycine diethyl ester |
168682-53-9 |
C27H35N3O6S |
|
EVACETRAPIB中间体 |
methyl 7,9-dimethyl-5-oxo-2,3,4,5-tetra-hydro-1H-benzo[b]azepine-1-carboxylate |
1259393-27-5 |
C14H17NO3 |
|
ETHYLONE盐酸盐 |
bk-MDEA (hydrochloride) |
1454266-19-3 |
C12H16ClNO3 |
|
ETHYL4,6-O-BENZYLIDENE-2-DEOXY-2-PHTHALIMIDO-1-THIO-Β-D-GLUCOPYRANOSIDE乙基4,6-O-亚苄基-2-脱氧-2-邻苯二甲酰亚氨基-1-硫代-Β-D-吡喃葡萄糖苷 |
ethyl 4,6-O-benzylidene-2-deoxy-2-N-phthalamido-1-thio-β-Dglucopyranoside |
99409-33-3 |
C23H23NO6S |
|
ETHYL3-O-(2-NAPHTHYL)METHYL-4,6-O-BENZYLIDENE-1-THIO-Β-D-GLUCOPYRANOSIDE乙基3-O-(2-萘基)甲基-4,6-O-亚苄基-1-硫代-Β-D-吡喃葡萄糖苷 |
ethyl 4,6-O-benzylidene-3-O-(2-naphthyl)methyl-1-thio-β-D-glucopyranoside |
352008-09-4 |
C26H28O5S |
|
ETHYL2,4,6-TRI-O-ACETYL-3-O-(2-NAPHTHYL)METHYL-1-THIO-Β-D-GLUCOPYRANOSIDE乙基2,4,6-三-O-乙酰基-3-O-(2-萘基)甲基-1-硫代-Β-D-吡喃葡萄糖苷 |
ethyl 2,4,6-tri-O-acetyl-3-O-(2-naphthyl)methyl-1-thio-β-D-glucopyranoside |
352008-02-7 |
C25H30O8S |
|
ETHYL 5-硝基-2-吡啶乙基甲苯 |
ethyl 5-nitropicolinate |
30563-98-5 |
C8H8N2O4 |
|
ESTRATETRAENONE甲酯 |
Equilin 3-methyl ether |
6030-83-7 |
C19H22O2 |
|
ERRΒ/Γ激动剂(GSK-4716) |
(E)-N'-(4-(diethylamino)benzylidene)-4-hydroxybenzohydrazide |
95167-41-2 |
C18H21N3O2 |
|
ERK抑制剂II,阴性对照 |
ERK Inhibitor II, Negative Control |
1177970-73-8 |
C18H12N6O |
|
EP杂质Q |
4,10beta-bis(acetyloxy)-13alpha-[[(2R,3S)-3-[[(3E)-hex-3-enoyl]amino]-2-hydroxy-3-phenylpropanoyl]oxy]-1,7beta-dihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate |
2243233-98-7 |
C46H55NO14 |
|
EPZ005687抑制剂 |
EPZ005687 |
1396772-26-1 |
C32H37N5O3 |
|
EPSILON-(GAMMA-L-谷氨酰)-L-赖氨酸 |
epsilon-(gamma-glutamyl)lysine |
17105-15-6 |
C11H21N3O5 |
|
EPA乙酯 |
Methyl (2E,4E,6E,8E,10E,12E)-docosa-2,4,6,8,10,12-hexaenoate |
28061-46-3 |
C23H34O2 |
|
EPA乙酯 |
eicosapentaenoic acid ethyl ester |
86227-47-6 |
C22H34O2 |
|
ENT-甲磺酸帕珠沙星 |
ent-Pazufloxacin Mesylate |
677004-96-5 |
C17H19FN2O7S |
|
ENT-他达拉非 |
(+/-) cis-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
629652-72-8 |
C22H19N3O4 |
|
ENS-163磷酸盐 |
ENS-163 phosphate |
117707-51-4 |
C11H19N2O5PS |
|
EMT抑制剂-1 |
4-((4-(3,4-dichlorophenyl)-1,2,5-thiadiazol-3-yl)oxy)butan-1-ol |
1638526-21-2 |
C12H12Cl2N2O2S |
|
EMPAGLIFLOZIN杂质104 |
(5-chloro-2-iodophenyl)(2-fluorophenyl)methanone |
76049-49-5 |
C13H7ClFIO |
|
EMD638683 (形态 S); (alphaS)-3,5-二氟-alpha-羟基苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰基)肼 |
N'-[(S)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide |
1184940-46-2 |
C18H18F2N2O4 |
|
EMD638683 (形态 R); (alphaR)-3,5-二氟-alpha-羟基苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰基)肼 |
N'-[(R)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide |
1184940-47-3 |
C18H18F2N2O4 |
|
EMD-1214063; 3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-哌啶基)甲氧基]-2-嘧啶基]苯基]甲基]-6-氧代-3-哒嗪基]苯腈 |
tepotinib |
1100598-32-0 |
C29H28N6O2 |
|
EMD 534085; N-[2-(二甲基氨基)乙基]-N'-[[(2R,4aS,5R,10bS)-3,4,4a,5,6,10b-六氢-5-苯基-9-(三氟甲基)-2H-吡喃并[3,2-c]喹啉-2-基]甲基]脲 |
EMD 534085 |
858668-07-2 |
C25H31F3N4O2 |
|
ELA锁链素 |
4-(16-(S)-amino-16-carboxybutyl)-1-(11-(S)-amino-11-carboxypentyl)-3,5-bis-(20,20’-(S)-amino-20,20’-carboxypropyl)pyridinium |
11003-57-9 |
C24H40N5O8 |
|
EIPA盐酸盐 |
ethylisopropyl amiloride hydrochloride |
1345839-28-2 |
C11H18ClN7O*ClH |
|
EGFR抑制剂 |
EGFR Inhibitor |
879127-07-8 |
C21H18F3N5O |
|
EGFR-IN-9(化合物8) |
N-{3-[4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]-pyrimidin-5-yl]phenyl}acrylamide |
1226549-39-8 |
C29H24N4O3 |
|
EED抑制剂(EEDINHIBITOR-1) |
MAK683 |
1951408-58-4 |
C20H17FN6O |
|
EDTMP钾 |
Tetrapotassium [({2-[bis(phosphonomethyl)amino]ethyl}azanediyl)bis(methylene)]bis(phosphonate) |
34274-30-1 |
C6H16K4N2O12P4 |
|
EDTA铁钾盐 |
Potassium ferric ethylenediaminetetraacetate |
54959-35-2 |
C10H12FeKN2O8 |
|
EDTA钙盐 |
Ethylenediaminetetraacetic acid dicalcium salt |
19709-85-4 |
C10H12Ca2N2O8 |
|
EDTA四铵 |
Tetraammonium ethylenediaminetetraacetate |
22473-78-5 |
C10H16N2O8.4H3N |
|
EDTA三钾盐二水合物 |
tripotassium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)azaniumyl]acetate;dihydrate |
—— |
C10H17K3N2O10 |
|
EDDP高氯酸盐标准品 |
(+/-)-2-ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium perchlorate |
31161-17-8 |
C20H24N*ClO4 |
|
EBP氯代物杂质 |
5'-Chloro eltrombopag |
376592-56-2 |
C25H21ClN4O4 |
|
EAM-1试剂 |
[2-(4-nitro-2,1,3-benzoxadiazol-7-yl)aminoethyl]trimethylammonium |
287970-46-1 |
C11H16N5O3 |
|
EA671;;二噻吩[3,2-E:2,3-G]-2,1,3-苯并噻二唑 |
dithieno[3',2':3,4;2'',3'':5,6]benzo[1,2-c][1,2,5]thiadiazole |
1256138-50-7 |
C10H4N2S3 |
|
E3330抑制剂 |
E 3330 |
136164-66-4 |
C21H30O6 |
|
E-阿魏酸二十二烷基酯 |
Docosylferulate |
101927-24-6 |
C32H54O4 |
|
E-邻甲基苯乙酮肟 |
E-ortho-methylacetophenone oxime |
68251-94-5 |
C11H15Br |
|
E-甲基-3-(5-甲酰基-2-呋喃基)-(2-对甲氧基苯基)丙烯酸酯 |
E-methyl-3-(5-formyl-2-furyl)-(2-p-methoxyphenyl) acrylate |
105199-78-8 |
C16H14O5 |
|
E-甲基-3-(2-呋喃基)-(2-甲基苯基)丙烯酸酯 |
E-methyl-3-(2-furyl)-(2-m-methylphenyl) acrylate |
105199-76-6 |
C15H14O3 |
|